📰 Immunization Practices News
Page 92 - Immunization Practices News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immunization Practices. Real-time updates on events, politics, business and more.
June 22, 2023
(CNN) — Adults 60 and older will be eligible to get a shot that could protect them from respiratory syncytial virus, or RSV, this fall if the US Centers for
June 22, 2023
Following a vote to recommend vaccines to prevent the spread of Respiratory Syncytial Virus (RSV) for adults aged 60 and older, the National Association of
June 22, 2023
CDC vaccine advisors said Wednesday that older adults in the United States should talk to their physicians about getting vaccinated against respiratory syncytial virus.
June 22, 2023
Twenty-nine cases seen in 2022, based on preliminary data, accounting for 9.8% of all meningococcal disease cases.
June 22, 2023
Nathan Posner/Anadolu Agency via Getty Images(WASHINGTON) -- A respiratory syncytial virus, or RSV, vaccine for older adults could soon be available after an advisory committee for the Centers for Disease Control and Prevention voted to recommend them Wednesday. During a meeting, the agencys Advisory Committee on Immunization Practices looked at clinical trial data for two vaccines, one by Pfizer and the other by GSK. Short of a full recommendation, the committee said adults aged 60 and over may...
June 21, 2023
It is a sign of enormous progress that vaccines are currently available to prevent more than 20 life-threatening diseases. And health and economic
June 21, 2023
GSK publishes positive data for its RSV older adult vaccine, Arexvy
June 21, 2023
A panel of advisers to the U.S. Centers for Disease Control and Prevention on Wednesday will vote on whether to recommend the use of recently approved vaccines from Pfizer and GSK to prevent... | June 21, 2023
June 21, 2023
New results from the ongoing AReSVi-006 phase III trial show vaccine efficacy against RSV-lower respiratory tract disease and severe disease over two full RSV seasons, including in participants with... | June 21, 2023
June 21, 2023
The U.S. Food and Drug Administration (FDA) last month warned in public guidance about the safety risks of unauthorized versions of Novo Nordisk's popular weight-loss drugs, which include Ozempic, Wegovy and Rybelsus, in response to reports of adverse health reactions to the "compounded" or custom-made variations. US CDC advisers weigh use of GSK, Pfizer RSV vaccines in older adults A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday will...